Although Medicare has been offering a lot of treatment and healthcare facilities to the people availing it, but till now it had been failing to present them with the coverage for the prescription costs. This had been a great difficulty for the beneficiaries since it had been a challenge for them to pay for the drugs themselves and then pay the premiums too. This also kept the people from asking their doctors to while them the brand name drugs as they are obviously expensive from the others and the people had to stick to the low priced drugs.
All the people availing the facilities from Medicare and who had been enrolled in some Medicare plans were looking up to Medicare to do something for them in this care. Now with the new Bipartisan Budget 2018, this problem has been solved and what people were waiting for since years has now been offered. Starting from the year 2019, the act has accelerated the closing of the Medicare Donut Hole 2019 and is offering the prescription relief to the people.
Now, the beneficiaries from Medicare, who had been availing the Medicare advantages can have the prescription costs as well if they reach the limit. The threshold limit for the beneficiaries is $5000 and if they have utilized it all, they can now apply for the Medicare help for the drug costs. For the rest of the year, Medicare is going to take care of all the prescription and the brand named drug charges and it will pay for the 95% of the costs while the beneficiary only has to pay 5% of the cost which is a great helping hand for those who are buying brand names.
The Affordable Care Act had been passed in the year 2010 and was effective since then. Gradually the donut hole had been closing and it was expected to get completely closed by the year 2020. However, the beneficiaries were surprised by the news that came along the Bipartisan Budget that the Donut hole will completely close by the beginning of the year 2019. Now the beneficiaries have the opportunity to choose the expensive and effective drugs as they can afford then now, while leaving the cheap yet less effective ones behind. We hope better changes from Medicare and FDA in the years to come.